Version Change details Date number V01.00 New MenACWY Risk Groups PHE PGD Template 01 February 2017 V02.00 MenACWY Risk Groups PGD amended to: 21 December 2018 include additional healthcare practitioners in Section 3 remove black triangle for Nimenrix® insert paragraph regarding coeliac disease refer to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Elizabeth Graham 24/01/2019 Pharmacist Lead Pharmacist - Immunisation (Lead Author) and Countermeasures, PHE Mary Ramsay Doctor Consultant Epidemiologist and 24/01/2019 Head of Immunisation and Countermeasures, PHE David Green 24/01/2019 Registered Nurse Nurse Consultant Immunisation – (Chair of Expert Panel) and Countermeasures, PHE This PGD has been peer reviewed by the PHE Immunisations PGD Expert Panel in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Advanced Paramedic Practitioner / Emergency Care Practitioner, Ed Gardner Medicines Manager, Proactive Care Lead Shamez Ladhani Paediatric Infectious Disease Consultant, Public Health England Vanessa Saliba Consultant Epidemiologist , Public Health England Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team
Version number Change details Date V01.00 New MenACWY Risk Groups PHE PGD Template 01 February 2017 V02.00 MenACWY Risk Groups PGD amended to: include additional healthcare practitioners in Section 3 remove black triangle for Nimenrix® insert paragraph regarding coeliac disease refer to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates 21 December 2018 PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Pharmacist (Lead Author) Elizabeth Graham Lead Pharmacist - Immunisation and Countermeasures, PHE 24/01/2019 Doctor Mary Ramsay Consultant Epidemiologist and Head of Immunisation and Countermeasures, PHE 24/01/2019 Registered Nurse (Chair of Expert Panel) David Green Nurse Consultant – Immunisation and Countermeasures, PHE 24/01/2019 This PGD has been peer reviewed by the PHE Immunisations PGD Expert Panel in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Ed Gardner Advanced Paramedic Practitioner / Emergency Care Practitioner, Medicines Manager, Proactive Care Lead Shamez Ladhani Paediatric Infectious Disease Consultant, Public Health England Vanessa Saliba Consultant Epidemiologist , Public Health England Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team